How We Are Treating COVID-19 Patients – UniAbuja Team Leader

The COVID-19 Team Leader at the University of Abuja Teaching Hospital, Dr. Yunusa Thairu, has explained the treatment regimen adopted in treating COVID-19 patients.

Thairu who made the disclosure on Monday while fielding questions from reporters after the official opening of the 506-bed space COVID-19 Isolation and Treatment Centre in Idu, Abuja said cocktail of an anti-retroviral drug, Aluvia, as well as Zinc and Vitamin C tablets are used in the treatment.

He said the treatment was adopted at a meeting with the World Health Organization (WHO) and the United Nations (UN).

“Lagos State started its protocol by using Aluvia with Vitamin C, Zinc and that was why we visited Lagos and then we saw the patients’ response.

“We found out that for us blacks, that a combination of Aluvia with Chloroquine will reduce the viral load.

“That is the protocol that we started at the University of Abuja Teaching Hospital right from the beginning.

“The treatment is for us to use Zinc, to allow the Aluvia enter into the cells to kill the virus and also unite it by Vitamin C.

“All of us know the role that Vitamin C plays in terms of allowing new cells to perform, so that those destroyed by the virus can grow.

“So, this is the treatment protocol. The treatment is Aluvia with Zinc, Chloroquine at the beginning which will help us actually recover and that is the success story of what we have,” he said.